logo cancerTo convegno medico 2018 Torino

PROGRAM

14.30 – 14.45 – Official greetings

14.45 – 14.55 – Introduction and program presentation (Federico BUSSOLINO – Eugenio BRUSA) 

OPENING LECTURE

14.55 – 15.20
Haifa SHEN – Methodist Hospital Research Institute, Houston (TX, USA)
Therapeutic Cancer NanoVaccine 

 

A ROLE FOR NANOSCIENCE IN CANCER IMMUNOTHERAPY

Chairs: Gloria BERLIER – Valentina CAUDA

15.20 – 15.45
Jen MORTON – Beatson Institute, CRUK Glasgow Center, Glasgow (UK)
Exploring opportunities for immunotherapy in mouse models of pancreatic cancer


15.45-16:10
Cornelis MELIEF – Department of Immunohematology and Blood Transfusion Leiden University Medical Center, Leiden, (NL) 
Combination immunotherapy of Cancer involving Therapeutics vaccination

16.15 – 16.45 – WORKSHOP SPONSOR
 

16.50 – 17.20 – SHORT TALKS SELECTED AMONG THE SUBMITTED ABSTRACTS

17.25 – 17.50
Anna SCHWENDEMAN – University of Michigan Ann Arbor, USA 
HDL Nanodiscs Discovery and Application for Cancer Immunotherapy   
17.50 – 18.15

Luisa DE COLA – Istituto di Ricerche Farmacologiche Mario Negri, Milan (I)

Nanocarriers for biomolecules delivery

18.20 – 18.40
VIRTUAL ROOM FOR POSTER PRESENTATION 

“JUST THE WOMAN I AM” KEYNOTE LECTURE

18.45 – 19.10
Elisabetta DEJANA – Department of Immunology, Genetics and Pathology, Uppsala (SE) 

Women and science: does the brain have a gender?

TUMOR MICROENVIRONMENT AND MODELS

Chairs: Valeria CHIONO – Clara MATTU

 

14.30– 14,55
Giulia ADRIANI – Singapore Immunology Network (SIgN) Agency for Science, Technology and Research. Singapore
3D microfluidic model of tumor microenvironment for pre-clinical screening of immunotherapies

 

14.55 – 15.20
David TING – Massachusetts General Hospital – Cancer Center, Boston (MA, USA) 
Single Cell Technologies to Define Intratumoral Heterogeneity 

 

15.20 – 15.45
Gabriele BERGERS – VIB-KU Leuven Center for Cancer Biology, Leuven (B) 
Creating an Immune-stimulating Tumor Microenvironment: a Vascular Perspective

 

15.45 – 16.15 – SHORT TALKS SELECTED AMONG THE SUBMITTED ABSTRACTS

 

16.15 – 16.45
Kairbaan HODIVALA-DILKE – Barts Cancer Institute London, London (UK) 
New routes for vascular modulation

 

16.45 – 17.10
Joao MANO – Department of Chemistry – University of Aveiro, Aveiro (Portugal
Soft biomaterials for engineering 3D cancer models

 

17.10 – 17.40 – SHORT TALKS SELECTED AMONG THE SUBMITTED ABSTRACTS

 

17.45 – 18.15 – WORKSHOP SPONSOR

 

18.20 – 18.40 – VIRTUAL ROOM FOR POSTER PRESENTATION  



CELL-BASED IMMUNOTHERAPY

Chairs: Paola CAPPELLO – Marco Agostino DERIU

 

18.45 – 19.10
Mariolina SALIO – MRC Human Immunology Unit, WIMM, University of Oxford, Oxford (UK)
Harnessing innate-like T cells in cancer immunotherapy

 

19.10 – 19.35
Samuel MOK – University of Texas – MD Anderson Cancer Center, Houston (TX, USA)
Anticancer immunotherapy by MFAP5 blockade suppresses ovarian cancer progression

 

MYELOID CELLS ORCHESTRATE TUMOR RESPONSE

Chair: Federico BUSSOLINO

14.30 – 14.55
Paola ALLAVENA – Humanitas University, Rozzano (I)
Macrophage Reprogramming using TLR-agonist-loaded Polymeric Nanocapsules for the treatment of Cancer 

 

14.55 – 15.20
Dmitry GABRILOVICH – AstraZeneca I Oncology R&D (USA) 
Regulation of tumor microenvironment by myeloid-derived suppressor cells 

 

15.20 – 15.30 – AWARDS ASSIGNMENT

 

15.35 – 16.05 – WORKSHOP SPONSOR

 

KEYNOTE LECTURE

16.10 – 16.35
Melody SWARTZ – Pritzker School of Molecular Engineering – University of Chicago (MI, USA) 



EMERGING TECHNOLOGIES IN CANCER IMMUNOLOGY

Chairs: Luca PRIMO – Alberto PULIAFITO

 

16.35 – 17.10
Massimiliano PAGANI – IFOM (The FIRC Institute for Molecular Oncology) e UNIMI, Milan (I) 
Organoid models to decipher the interplay between tumor and the immune system

 

17.10 – 17.35
Giovanni CIRIELLO – Université de Lausanne, Lausanne, (CH)

Cancer Evolutionary Dependencies

 

17.35 – 18.00
Jérome GALON – Laboratory of Integrative Cancer Immunology, Sorbonne Université, Sorbonne Paris (F)
The immune contexture in the era of cancer immunotherapy

 

18.00 – 18.25
Henner FARIN – Georg-Speyer-Haus – Institute Tumor Biology and Experimental Therapy, Frankfurt (D)
Patient-derived tumor organoids to model stromal interactions and cell-based immunotherapies 

 

18.25 – 18.40
Concluding Remarks – (Federico BUSSOLINO – Eugenio BRUSA)




Made with CUS Torino